Merck KGaA Moves MS Hopeful Evobrutinib To Phase III, Plans Pipeline Update

 
• By Sten Stovall
  
Merrck
German Merck Group Will Hold A Capital Market Day On 11 Sept • Source: Shutterstock

More from Business

More from Scrip